Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110910717 | 11091071 | 7 | F | 20160919 | 20150505 | 20160922 | PER | US-PFIZER INC-2015144310 | PFIZER | 63.00 | YR | F | Y | 66.67000 | KG | 20160922 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110910717 | 11091071 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | UNK | Y | 21446 | CAPSULE, HARD | ||||||||
| 110910717 | 11091071 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 475 MG, UNK | Y | 21446 | 475 | MG | CAPSULE, HARD | ||||||
| 110910717 | 11091071 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 375 MG, UNK | Y | 21446 | 375 | MG | CAPSULE, HARD | ||||||
| 110910717 | 11091071 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, UNK | Y | 21446 | 150 | MG | CAPSULE, HARD | ||||||
| 110910717 | 11091071 | 5 | SS | LYRICA | PREGABALIN | 1 | Oral | 75MG OF LYRICA IN THE MORNING AND 150MG OF LYRICA IN THE EVENING | Y | 21446 | CAPSULE, HARD | BID | |||||||
| 110910717 | 11091071 | 6 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 3X/DAY | Y | N17632 | 21446 | 150 | MG | CAPSULE, HARD | TID | ||||
| 110910717 | 11091071 | 7 | C | CLONIDINE. | CLONIDINE | 1 | 0.2 MG, 2X/DAY | 0 | .2 | MG | BID | ||||||||
| 110910717 | 11091071 | 8 | C | IRBESARTAN. | IRBESARTAN | 1 | 150 MG, 2X/DAY | 0 | 150 | MG | BID | ||||||||
| 110910717 | 11091071 | 9 | C | BISOPROLOL FUMARATE. | BISOPROLOL FUMARATE | 1 | 10 MG, 2X/DAY | 0 | 10 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110910717 | 11091071 | 1 | Fibromyalgia |
| 110910717 | 11091071 | 2 | Neuralgia |
| 110910717 | 11091071 | 7 | Hypertension |
| 110910717 | 11091071 | 8 | Hypertension |
| 110910717 | 11091071 | 9 | Blood pressure abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110910717 | 11091071 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110910717 | 11091071 | Acidosis | |
| 110910717 | 11091071 | Bedridden | |
| 110910717 | 11091071 | Constipation | |
| 110910717 | 11091071 | Dizziness | |
| 110910717 | 11091071 | Drug dispensing error | |
| 110910717 | 11091071 | Drug intolerance | |
| 110910717 | 11091071 | Feeling abnormal | |
| 110910717 | 11091071 | Gait disturbance | |
| 110910717 | 11091071 | Gastric disorder | |
| 110910717 | 11091071 | Hypertension | |
| 110910717 | 11091071 | Intentional product misuse | |
| 110910717 | 11091071 | Malaise | |
| 110910717 | 11091071 | Mobility decreased | |
| 110910717 | 11091071 | Nausea | |
| 110910717 | 11091071 | Pain | |
| 110910717 | 11091071 | Paraesthesia | |
| 110910717 | 11091071 | Peripheral swelling | |
| 110910717 | 11091071 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110910717 | 11091071 | 1 | 2006 | 0 |